A detailed history of Israel Englander (Millennium Management LLC) transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 114,613 shares of TVTX stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,613
Previous 2,949,335 96.11%
Holding current value
$2.05 Million
Previous $24.2 Million 93.39%
% of portfolio
0.0%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.89 - $15.21 $22.4 Million - $43.1 Million
-2,834,722 Reduced 96.11%
114,613 $1.6 Million
Q2 2024

Aug 14, 2024

BUY
$5.26 - $8.28 $3.93 Million - $6.19 Million
747,406 Added 33.94%
2,949,335 $24.2 Million
Q1 2024

May 15, 2024

BUY
$7.18 - $9.82 $6.51 Million - $8.91 Million
907,343 Added 70.09%
2,201,929 $17 Million
Q4 2023

Feb 14, 2024

BUY
$5.44 - $9.5 $3.64 Million - $6.36 Million
669,983 Added 107.27%
1,294,586 $11.6 Million
Q2 2023

Aug 14, 2023

SELL
$15.3 - $22.61 $7.65 Million - $11.3 Million
-499,735 Reduced 44.45%
624,603 $9.59 Million
Q1 2023

May 15, 2023

BUY
$17.82 - $22.89 $4.69 Million - $6.03 Million
263,293 Added 30.58%
1,124,338 $25.3 Million
Q4 2022

Feb 14, 2023

BUY
$18.47 - $26.14 $4.84 Million - $6.85 Million
262,046 Added 43.75%
861,045 $18.1 Million
Q3 2022

Nov 14, 2022

BUY
$22.91 - $28.63 $9.31 Million - $11.6 Million
406,183 Added 210.66%
598,999 $14.8 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.15B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.